Good Morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stock futures were down on Tuesday. Traders are looking at the latest announcements from Nvidia’s artificial intelligence conference. The chip giant pulled back 1.5% in premarket trading (more on that below) and Wall Street is waiting on the next move for monetary policy. The Federal Reserve begins its two-day policy meeting Tuesday.

It’s almost Wednesday, the day our Head Trading Tactician Bryan Bottarelli makes one simple 7-minute trade that he’s guaranteeing an 80% win rate on.

Click here to unlock Bryan’s secret trading strategy and get the next pick.

Here’s a look at the top-moving stocks this morning.

Fusion Pharmaceuticals (Nasdaq: FUSN)

Fusion Pharmaceuticals is up 95.86% in premarket after AstraZeneca announced it will buy the clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash. The Anglo-Swedish drugmaker is betting on next-generation cancer treatments. The deal is AstraZenca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion.

StoneCo Ltd. (Nasdaq: STNE)

StoneCo Ltd is down 9.58% premarket despite a rise in Q4 earnings and revenue. However, the company subsequently announced changes to its board, with Founder Andre Street deciding not to seek re-election at the upcoming Annual General Meeting, which will take hold by the end of April. Vice chairman Conrado Engel not seeking re-election.